Skip to content

Dr. Jorne Van Overloop

Active
Private limited companyfounded 20179 years activeHondschotestraat 218, 8560 Wevelgem, BelgiumKBO/BCE: BE 0670.539.323
Summary

Dr. Jorne Van Overloop has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €196,834. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 13% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€211,579total assets 2025
Equity
€18,600
Profit
€196,834
Turnover not published (abridged schema)
Financial health
90 Excellent Checked score 2025
Bankruptcy probability, 12 months
0.1%
Structure
Accounts 56 days early1 of 3 deeds read
Why 90- 1 change of registered office in 24 months- Equity €18,600 (8.8% of total assets)+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 1.02, cash €77,127Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 34+3
equity 8.8% of total assets
Liquidity 52-3
short-term debt 79.5% · cash 36.5%
Profitability 100=
return on assets 93.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,969 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026highest value 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit up to €1,500 at 30 days acceptable
Liquidity tight (current ratio 1.02 against 1.01 in 2024; short-term debt: 79.5% and cash: 36.5% of total assets), and 91.2% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 13% on solvency, 25% on liquidity, 80% on profitability and 36% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian State Gazette
lowers risk · Liquidity: current ratio 1.02, cash €77,127
NBB · annual accounts
raises risk · Equity €18,600 (8.8% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 20374 sector peers (2025).
NBB · sector comparison
Position among 20374 sector peers
Solvency
better than 13%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
56 days early
2024
29 days early
2023
36 days early
2022
31 days late
2021
22 days late
2020
26 days late
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 July (4 of the last 5 filed years within 51 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Registered officeRegistered office clause · Registered-office…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: Among the weakest 13% on solvencysector median 63.3% · 20,374 companies 8.8% View
  • Positive: 5 profitable years in a rowprofit 2025: €196,834 5 years View
  • Total assets 20256 fiscal years filed €211,579 View

By topic

Financials

Fiscal year
2025
Total assets
€211,579
Profit
€196,834
Solvency
8.8%
Total assets▼ 28.7%
Net result
20182025
Go to Financials

Timeline

Events
15
Since
2018
Next accounts
by 31-07-2027
  1. 31-12-2024Highest result since 2018
  2. 25-06-2024Annual accounts filed
  3. 31-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
30-01-2017
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.